meRfi®-GM
Antibiotics & Clostridioides difficile infection (CDI)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Antibiotics reduce the overall diversity of the gut microbiota (dysbiosis), leading to Clostridioides difficile infection (CDI) through the abnormal proliferation of Clostridioides (Clostridium) difficile.
Antibiotic use is one of the major risk factors for C difficile infection, and antibiotic-mediated perturbation of the gut microbiota in those with this infection has been c…
References (Sources)
- Microbiologic factors affecting Clostridium difficile recurrence
- Role of the Gut Microbiota in Resistance to Colonization by Clostridium difficleReview
- The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine−Dependent but GPR43/109a-Independent Mechanisms
- The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications